Teledyne reports all-time best quarter sales
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
New Westlake Village biotech center could see first tenants in 2027
Life sciences tenants could begin moving into a new biotech center in Westlake Village as soon as next year. The approximately 100,000-square-foot property was acquired in early 2023 by San Francisco-based Graymark Capital in partnership with Argosy Real Estate Partners. The former headquarters of Anthem Blue Cross, the facility, now named Westlake Labs, has been Read More →
Atara receives action date for tabcel
Thousand Oaks-based Atara Biotherapeutics announced that its partner, Pierre Fabre Pharmaceuticals, received acceptance by the U.S. Food and Drug Administration of the Biologics License Application for tabelecleucel, Atara’s lead product, on Oct. 14. With the notice, the FDA also set a target action date for the drug on March 31. Tabelecleucel, sold under the brand Read More →
Keynote speaker: Housing market like a martini glass
Like many other high-cost areas, the Ventura County housing market resembles a martini glass, keynote speaker Bill Fulton said at the 25th annual Ventura County Housing Conference. The bowl at the top of the glass is very full of luxury housing, he said. There’s some affordable housing production at the base. But the glass’s stem is very thin, Read More →
Atara resubmits Ebvallo BLA to FDA
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
An inside look at Latigo’s 2026 IPO
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Longtime Teledyne executive announces retirement
Jason VanWees, Teledyne Technologies’ Vice Chairman, announced that he will be retiring from his position on Feb. 1, 2027, at age 55. VanWees joined Teledyne before the company’s spin-off in 1999 and was named vice chairman in 2021. He spoke at a Ventech event in Santa Barbara in 2023, detailing Teledyne’s legacy as well as Read More →
